Fact sheet

Name:

Bioxyne Limited

Business Description:

Bioxyne Limited (ASX:BXN) is an Australian life sciences and health products company with a focus on immune health and immunotherapeutic products

Through our recent acquisition in New Zealand, now trading as Bioxyne International, we are further developing a range of existing functional foods and beauty products containing ingredients sourced exclusively from New Zealand, for our direct sales channel.

Bioxyne has a strategic investment in the consumer dietary supplements and functional foods markets through its proprietary probiotic, Lactobacillus fermentum PCC®. Bioxyne is a company creating value for consumers and investors by delivering safe and effective solutions.

Bioxyne’s focus is currently on the company’s probiotic business and proprietary product Lactobacillus fermentum PCC® which is supported by a manufacturing and distribution agreement with Chr. Hansen (Denmark) a global leader in the manufacturing of natural food additives and supplements products for the food, health, pharmaceutical and agriculture industries.

Bioxyne also has a distribution agreement with Nu-Skin Enterprises (USA) a successful worldwide multilevel marketing company who pride themselves in offering only quality solutions to their customers.

Shares on Issue:

Ordinary shares: 507,565,250
Options: 917,000 exercisable at $0.021 on or before 10 December 2017
Class A Options: 2,750,000 exercisable at $0.0234 on or before 24 November 2019
Employee Options: 1,250,000 exercisable at $0.0234 on or before 24 November 2019
Unlisted Options: 126,891,336 exercisable at $0.01 before 15 December 2017

Listings:

ASX

Managing Director and Chief Executive Officer

Mr N H Chua

Chief Financial Officer:

Guy Robertson

Board of Directors:

Mr Anthony Ho - Non Executive Chairman
Mr N H Chua - Managing Director and CEO
Patrick Ford - Non-Executive Director
Dr Peter French - Executive Director
Mr Maxwell Parkin - Executive Director

Company Secretary:

Guy Robertson

Registered Office:

Suite 506, Level 5
50 Clarence Street
Sydney NSW 2000

P: + 61 2 9078 8180
E: info@bioxyne.com

Phone:

+61 2 9078 8180

Fax:

+6102 9078 7661

Web:

http://www.bioxyne.com

Share Registry:

Computer Share Investor Services Pty Limited

Level 4, 60 Carrington Street
SYDNEY, NSW 2000
Australia

Phone: 1300 787 272 (within Australia)
              +61 3 9415 4088 (outside Australia)
Fax:

Auditor:

RSM Australia Partners

Level 13, 60 Castlereagh Street
Sydney NSW 2000

+61 2 8226 4500

Bioxyne Ltd.

Suite 506, Level 5
50 Clarence St
Sydney, NSW 2000, Australia

P: +61 2 9078 8180
E: info@bioxyne.com
ABN: 97 084 464 193

Home

Sign Up